JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (1992) 8 145-153    DOI: 10.1677/jme.0.0080145
© 1992 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hughes, S. J.
Right arrow Articles by Ashcroft, S. J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughes, S. J.
Right arrow Articles by Ashcroft, S. J. H.

Stimulation of insulin release by vasopressin in the clonal β-cell line, HIT-T15: the role of protein kinase C

S. J. Hughes, A. Carpinelli, I. Niki, J. L. Nicks and S. J. H. Ashcroft

We have studied the effects of vasopressin and tetradecanoyl phorbol acetate (TPA) on cytosolic free Ca2+ ([Ca2+]i) and insulin release in HIT-T15 β-cells. Saturable binding of [3H] [Arg8]-vasopressin to HIT cell microsomes indicated a single class of receptors with a dissociation constant (Kd) of 2.5 nM and a total number of binding sites (Bmax) equal to 120 fmol/mg protein. [Arg8]-vasopressin (0.1–100 nM) elicited dose-dependent insulin release from HIT cells by up to 25-fold. This increase was dependent on the presence of extracellular glucose and was blocked by omission of extracellular Ca2+ or addition of verapamil. The stimulation was biphasic; a rapid but short-lived large increase in release was followed by a smaller sustained rise. Vasopressin also evoked a marked, concentration-dependent increase in [Ca2+]i which was also biphasic; an initial spike was followed by a sustained elevation. This increase also required glucose and was blocked by the absence of extracellular Ca2+ or the addition of verapamil. Pretreatment of the cells with TPA overnight to deplete protein kinase C activity did not affect the [Ca2+]i or insulin responses to vasopressin. However, short-term exposure to TPA markedly reduced glucose-induced steady-state [Ca2+]i, despite potentiating glucose-stimulated insulin release sevenfold, and blocked the [Ca2+]i increase induced by vasopressin. These inhibitory effects of TPA were absent in protein kinase C-depleted cells and were prevented by staurosporine. TPA had no significant effect on vasopressin-induced insulin release. Vasopressin did not modify the activity of ATP-sensitive K+ channels. These data indicate that vasopressin-induced insulin release is associated with a large increase in [Ca2+]i via increased Ca2+ entry and that this signal is markedly reduced by protein kinase C activation. Thus, protein kinase C does not have a direct role in vasopressin-induced insulin release. Simultaneous addition of vasopressin and TPA promotes insulin release, possibly through increased sensitivity of the secretory system to Ca2+ on activation of protein kinase C by TPA.




This article has been cited by other articles:


Home page
DiabetesHome page
M. J. Holness, N. D. Smith, G. K. Greenwood, and M. C. Sugden
Acute {omega}-3 Fatty Acid Enrichment Selectively Reverses High-Saturated Fat Feeding-Induced Insulin Hypersecretion But Does Not Improve Peripheral Insulin Resistance
Diabetes, February 1, 2004; 53(90001): S166 - 171.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. J. Holness, G. K. Greenwood, N. D. Smith, and M. C. Sugden
Diabetogenic Impact of Long-Chain {omega}-3 Fatty Acids on Pancreatic {beta}-Cell Function and the Regulation of Endogenous Glucose Production
Endocrinology, September 1, 2003; 144(9): 3958 - 3968.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. C. Sugden, G. K. Greenwood, N. D. Smith, and M. J. Holness
Peroxisome Proliferator-Activated Receptor-{alpha} Activation during Pregnancy Attenuates Glucose-Stimulated Insulin Hypersecretion in Vivo by Increasing Insulin Sensitivity, without Impairing Pregnancy-Induced Increases in {beta}-Cell Glucose Sensing and Responsiveness
Endocrinology, January 1, 2003; 144(1): 146 - 153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Schofl, J. Borger, T. Mader, M. Waring, A. von zur Muhlen, and G. Brabant
Tolbutamide and diazoxide modulate phospholipase C-linked Ca2+ signaling and insulin secretion in beta -cells
Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E639 - E647.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the Society for Endocrinology.